Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-09-01

Clinical Trial Update: the Effect of Dexmedetomidine and Magnesium Sulfate in Open Resection of Pheochromocytoma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating dexmedetomidine and magnesium sulfate in open resection of pheochromocytoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dexmedetomidine (Dexmedetomidine)
  • Magnesium sulfate (magnesium sulfate)

Snippet

Sponsor: National Cancer Institute, Egypt | Conditions: Pheochromocytoma | Phase 2 | Status: COMPLETED